Xiduo Pharmaceuticals released the half-year report for 2024. During the reporting period, the revenue was 0.129 billion yuan, a year-on-year increase of 13.04%; the net income attributable to the owners of the parent company was 24.4517 million yuan, a decrease of 19.36% year-on-year.
西点药业：上半年净利润同比下降19.36%
Xiduo Pharmaceuticals: The net income in the first half of the year decreased by 19.36% compared to the same period last year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.